Former Indivior CEO pleads guilty in U.S. in opioid addiction treatment probe
Nate Raymond
Reuters
June 30th, 2020
Nate Raymond
Reuters
June 30th, 2020
Read the full story here.(Reuters) - Shaun Thaxter, the former chief executive of drugmaker Indivior Plc (INDV.L), pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investigation into the marketing of its opioid addiction treatment Suboxone.
Thaxter pleaded guilty in federal court in Abingdon, Virginia to a misdemeanor count of introducing misbranded drugs into interstate commerce. The plea came a day after Indivior said he was stepping down as CEO.
Prosecutors said Thaxter failed to prevent employees from sharing misleading safety information about the drug with Massachusetts’ Medicaid program as it considered expanding coverage for it.
Wick Sollers, his attorney, said Thaxter was “unaware of the alleged misstatements when they were made.” Thaxter faces up to one year in prison when he is sentenced on Sept. 29 and has agreed to pay $600,000 in fines and forfeitures.